Cantor Fitzgerald Remains a Hold on Molina Healthcare (MOH)
Cantor Fitzgerald analyst Sarah James reiterated a Hold rating on Molina Healthcare today and set a price target of $209.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
James covers the Healthcare sector, focusing on stocks such as TruBridge, Acadia Healthcare, and Molina Healthcare. According to TipRanks, James has an average return of 5.7% and a 57.05% success rate on recommended stocks.
In addition to Cantor Fitzgerald, Molina Healthcare also received a Hold from Goldman Sachs’s Scott Fidel in a report issued today. However, on the same day, Bank of America Securities maintained a Buy rating on Molina Healthcare (NYSE: MOH).
Based on Molina Healthcare’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $10.8 billion and a net profit of $14 million. In comparison, last year the company earned a revenue of $11.15 billion and had a net profit of $298 million
Based on the recent corporate insider activity of 57 insiders, corporate insider sentiment is neutral on the stock. Most recently, in March 2026, Ronna Romney, a Director at MOH sold 506.00 shares for a total of $74,341.52.
Read More on MOH:
Disclaimer & DisclosureReport an Issue
- Molina Healthcare price target raised to $163 from $124 at Baird
- Balanced Risk-Reward Keeps Molina Healthcare at Hold Amid Conservative 2029 Growth and Margin Assumptions
- Molina Healthcare backs FY26 adjusted EPS view of greater than $5.00
- Molina sees premium growth of 14% to about $48B in 2027
- Molina Healthcare targets 2029 adjusted EPS $20-$30
